Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-21

Clinical Trial Update: Anti-gingivitis Mouthrinse [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating an anti-gingivitis mouthrinse has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colgate Anti-Gingivitis Mouthrinse

Snippet

Sponsor: Colgate Palmolive | Conditions: Gingivitis | Phase 3 | Status: COMPLETED